Tiapride is an investigational drug.
There have been 5 clinical trials for Tiapride.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2008.
The most common disease conditions in clinical trials are Disease, Somatoform Disorders, and Tourette Syndrome. The leading clinical trial sponsors are Beersheva Mental Health Center, Assistance Publique - Hôpitaux de Paris, and Tasly Pharmaceuticals, Inc.